Summary
17.48 0.52(3.07%)09/13/2024
Cellebrite DI (CLBT)
Cellebrite DI (CLBT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 3.07 | -6.91 | 21.36 | 34.07 | 45.30 | 94.07 | 0.00 | -51.69 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 17.48 | |
| Open | 16.96 | |
| High | 17.54 | |
| Low | 16.96 | |
| Volume | 657,729 | |
| Change | 0.52 | |
| Change % | 3.07 | |
| Avg Volume (20 Days) | 1,117,179 | |
| Volume/Avg Volume (20 Days) Ratio | 0.59 | |
| 52 Week Range | 5.24 - 12.50 | |
| Price vs 52 Week High | 39.84% | |
| Price vs 52 Week Low | 233.59% | |
| Range | -2.30 | |
| Gap Up/Down | -0.05 | |
Fundamentals | ||
| Market Capitalization (Mln) | 3,644 | |
| EBIDTA | 20,918,000 | |
| PE Ratio | 149.4545 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 14.33 | |
| Book Value | 0.6180 | |
| Earnings Per Share | 0.0550 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.2100 | |
| EPS Estimate Next Year | 0.1800 | |
| Diluted EPS (TTM) | 0.0550 | |
| Revenues | ||
| Profit Marging | 0.0955 | |
| Operating Marging (TTM) | 0.0619 | |
| Return on asset (TTM) | 0.0000 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 235,506,000 | |
| Revenue per share TTM | 1.7500 | |
| Quarterly Revenue Growth (YOY) | 0.2380 | |
| Quarterly Earnings Growth (YOY) | 0.6670 | |
| Gross Profit (TTM) | 157,034,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 149.4545 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.0000 | |
| Revenue Enterprise Value | 0.0000 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 187,260,992 | |
| Shares Float | 27,750,885 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 7.55 | |
| Institutions (%) | 11.73 | |
08/30 08:00 EST - globenewswire.com
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the “Redemption Fair Market Value” in connection with its previously announced redemption of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”).
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the “Redemption Fair Market Value” in connection with its previously announced redemption of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”).
08/26 20:55 EST - seekingalpha.com
Cellebrite: Rating Downgrade As Valuation Has Caught Up
Cellebrite's 2Q24 results exceeded expectations with solid revenue growth and profit metrics. Progress in key metrics and initiatives indicate potential for >20% growth in the future. CLBT's Valuation has caught up, making the upside less attractive despite a positive fundamental outlook.
Cellebrite: Rating Downgrade As Valuation Has Caught Up
Cellebrite's 2Q24 results exceeded expectations with solid revenue growth and profit metrics. Progress in key metrics and initiatives indicate potential for >20% growth in the future. CLBT's Valuation has caught up, making the upside less attractive despite a positive fundamental outlook.
08/19 13:21 EST - zacks.com
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
08/16 10:46 EST - zacks.com
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
08/16 10:17 EST - zacks.com
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
08/15 20:52 EST - seekingalpha.com
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
08/15 09:16 EST - zacks.com
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.
08/15 07:05 EST - globenewswire.com
Cellebrite Announces Second-Quarter 2024 Results
Revenue of $95.7 million, 25% year-over-year increase primarily due to 27% growth in subscription revenue; ARR of $345.9 million, up 26% year-over-year; Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin; Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR
Cellebrite Announces Second-Quarter 2024 Results
Revenue of $95.7 million, 25% year-over-year increase primarily due to 27% growth in subscription revenue; ARR of $345.9 million, up 26% year-over-year; Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin; Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR
08/15 07:00 EST - globenewswire.com
Cellebrite Announces Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today that it will redeem all of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”) that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 (the “Redemption Date”) for a redemption price of $0.10 per Warrant.
Cellebrite Announces Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today that it will redeem all of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”) that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 (the “Redemption Date”) for a redemption price of $0.10 per Warrant.
08/14 07:00 EST - globenewswire.com
Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors
Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally
Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors
Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally
08/01 08:30 EST - globenewswire.com
Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer
Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform
Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer
Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform
07/30 09:00 EST - prnewswire.com
Relativity and Cellebrite Partner to Unleash the Power of Mobile Data
Collaboration between two powerhouses will deliver innovative solutions for seamless mobile device collection, processing and review CHICAGO and TYSONS CORNER, Va. and PETAH TIKVA, Israel , July 30, 2024 /PRNewswire/ -- Relativity, a global legal technology company, and Cellebrite (Nasdaq: CLBT), a global leader in digital investigative solutions, today announced a strategic partnership that will deliver cutting-edge solutions for mobile device collection, processing and review.
Relativity and Cellebrite Partner to Unleash the Power of Mobile Data
Collaboration between two powerhouses will deliver innovative solutions for seamless mobile device collection, processing and review CHICAGO and TYSONS CORNER, Va. and PETAH TIKVA, Israel , July 30, 2024 /PRNewswire/ -- Relativity, a global legal technology company, and Cellebrite (Nasdaq: CLBT), a global leader in digital investigative solutions, today announced a strategic partnership that will deliver cutting-edge solutions for mobile device collection, processing and review.
07/23 10:16 EST - zacks.com
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
07/18 09:10 EST - zacks.com
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?
Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume.
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?
Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume.
07/17 07:30 EST - globenewswire.com
Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
Launches Cellebrite Federal Solutions with the acquisition of Cyber Technology Services, Inc. and the appointment of four renowned independent directors Launches Cellebrite Federal Solutions with the acquisition of Cyber Technology Services, Inc. and the appointment of four renowned independent directors
Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
Launches Cellebrite Federal Solutions with the acquisition of Cyber Technology Services, Inc. and the appointment of four renowned independent directors Launches Cellebrite Federal Solutions with the acquisition of Cyber Technology Services, Inc. and the appointment of four renowned independent directors
07/11 09:06 EST - seekingalpha.com
Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate
Cellebrite has a strong competitive advantage as the gold standard in digital forensics, making it difficult for new players to replicate or displace. CLBT serves a mission-critical function in digital investigations for law enforcement, with a majority of revenue coming from subscriptions. Up/cross selling opportunities and penetration into adjacent functions are key drivers for CLBT's future earnings growth.
Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate
Cellebrite has a strong competitive advantage as the gold standard in digital forensics, making it difficult for new players to replicate or displace. CLBT serves a mission-critical function in digital investigations for law enforcement, with a majority of revenue coming from subscriptions. Up/cross selling opportunities and penetration into adjacent functions are key drivers for CLBT's future earnings growth.
07/09 08:30 EST - globenewswire.com
Cellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 09, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its second-quarter 2024 financial results before market open on Thursday, August 15, 2024.
Cellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 09, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its second-quarter 2024 financial results before market open on Thursday, August 15, 2024.
06/26 08:30 EST - globenewswire.com
Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
Endpoint Inspector SaaS accelerates, expands and simplifies access to secure data collection and analysis Endpoint Inspector SaaS accelerates, expands and simplifies access to secure data collection and analysis
Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
Endpoint Inspector SaaS accelerates, expands and simplifies access to secure data collection and analysis Endpoint Inspector SaaS accelerates, expands and simplifies access to secure data collection and analysis
05/23 15:09 EST - seekingalpha.com
Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2024 Earnings Call Transcript May 23, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Shaul Eyal - TD Cowen Jonathan Ho - William Blair Mike Cikos - Needham Eric Martinuzzi - Lake Street Brian Essex - JPMorgan Jeff Van Rhee - Craig-Hallum Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2024 Earnings Call Transcript May 23, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Shaul Eyal - TD Cowen Jonathan Ho - William Blair Mike Cikos - Needham Eric Martinuzzi - Lake Street Brian Essex - JPMorgan Jeff Van Rhee - Craig-Hallum Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
05/23 09:11 EST - zacks.com
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share.
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share.